Ameriprise
CGEN icon

Ameriprise’s Compugen CGEN Stock Holding History

Ameriprise’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,215
Closed -$26.4K – 3872
2024
Q1 		$26.4K Sell
10,215
-650
-6% -$1.51K ﹤0.01% 3827
2023
Q4 		$21.5K Buy
10,865
+650
+6% +$568 ﹤0.01% 3874
2023
Q3 		$9.5K Hold
10,215
– – ﹤0.01% 3875
2023
Q2 		$11.6K Sell
10,215
-243
-2% -$212 ﹤0.01% 3889
2023
Q1 		$7.34K Sell
10,458
-1,000
-9% -$822 ﹤0.01% 3923
2022
Q4 		$8K Sell
11,458
-5,100
-31% -$4.45K ﹤0.01% 3938
2022
Q3 		$11K Sell
16,558
-2,200
-12% -$3.11K ﹤0.01% 3936
2022
Q2 		$35K Sell
18,758
-101
-0.5% -$218 ﹤0.01% 3838
2022
Q1 		$61K Sell
18,859
-500
-3% -$1.69K ﹤0.01% 3872
2021
Q4 		$83K Sell
19,359
-4,367
-18% -$23.6K ﹤0.01% 3882
2021
Q3 		$142K Sell
23,726
-27,062
-53% -$181K ﹤0.01% 3746
2021
Q2 		$421K Buy
50,788
+600
+1% +$4.87K ﹤0.01% 3519
2021
Q1 		$431K Buy
50,188
+7,625
+18% +$84.6K ﹤0.01% 3468
2020
Q4 		$507K Buy
42,563
+4,598
+12% +$63.4K ﹤0.01% 3341
2020
Q3 		$617K Buy
+37,965
New +$622K ﹤0.01% 3167
2014
Q4 		– Sell
-150
Closed -$1K – 3785
2014
Q3 		$1K Hold
150
– – ﹤0.01% 5544
2014
Q2 		$1K Sell
150
-400
-73% -$3.6K ﹤0.01% 5330
2014
Q1 		$6K Buy
+550
New +$6.06K ﹤0.01% 4726

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Ameriprise's CGEN Position: Q2 2024 in Review

Ameriprise sold out of Compugen (CGEN) in Q2 2024, closing a stake of 10,215 shares — an estimated $26.4K sold.

Ameriprise first reported a position in CGEN in Q1 2014 and held it in 18 quarters. The position peaked at $617K in Q3 2020. 66 funds tracked by Wall St. Rank hold CGEN as of Q2 2024.

  • Ameriprise reported no remaining Compugen position as of Q2 2024 after selling out during the quarter.
  • Ameriprise sold 10,215 Compugen shares in Q2 2024, an estimated $26.4K.
  • Ameriprise first reported a position in Compugen in Q1 2014 and held it in 18 quarters.
  • Ameriprise's Compugen position peaked at $617K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held Compugen as of Q2 2024.

Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.